提高心房颤动认知度：是时候超越表面了吗？
Building Atrial Fibrillation Awareness: Is it Time to get Beyond the Top Line?
作者信息
Saksena Sanjeev
机构信息
Electrophysiology Research Foundation, Warren, NJ, and the Department of Medicine, UMDNJ- Robert Wood Johnson Medical School Warren and Piscataway, NJ.
出版信息
J Atr Fibrillation. 2013 Jun 30;6(1):908. doi: 10.4022/jafib.908. eCollection 2013 Jun-Jul.
Abstract
Public awareness of atrial fibrillation and its consequences is increasing. In the current environment, this is driven largely by promotion of individual therapies. This editorial discusses the need for greater depth in the discussion of the disease state, its progression and economic consequences as well as the risk of death and disability. The adverse effects of therapies on cardiovascular outcomes is a major need in public education. New initiatives should address these important new insights and needs.
摘要
公众对心房颤动及其后果的认识正在提高。在当前环境下，这很大程度上是由个别疗法的推广所推动的。这篇社论讨论了在疾病状态、其进展、经济后果以及死亡和残疾风险的讨论中需要更深入探讨的问题。疗法对心血管结局的不良影响是公众教育中的一项主要需求。新的举措应解决这些重要的新见解和需求。
相似文献
1
Building Atrial Fibrillation Awareness: Is it Time to get Beyond the Top Line?
J Atr Fibrillation. 2013 Jun 30;6(1):908. doi: 10.4022/jafib.908. eCollection 2013 Jun-Jul.
2
Atrial fibrillation in the elderly: facts and management.
Drugs Aging. 2002;19(11):819-46. doi: 10.2165/00002512-200219110-00002.
4
Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis.
BMJ. 2016 Sep 6;354:i4482. doi: 10.1136/bmj.i4482.
5
Recent progress in the epidemiology of atrial fibrillation.
Curr Opin Cardiol. 2005 Jan;20(1):7-14.
6
Relationship of Age With Stroke and Death in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: AMADEUS Trial.
Stroke. 2015 Nov;46(11):3202-7. doi: 10.1161/STROKEAHA.115.010614. Epub 2015 Oct 13.
7
Systolic Blood Pressure Visit-to-Visit Variability and Major Adverse Outcomes in Atrial Fibrillation: The AFFIRM Study (Atrial Fibrillation Follow-Up Investigation of Rhythm Management).
Hypertension. 2017 Nov;70(5):949-958. doi: 10.1161/HYPERTENSIONAHA.117.10106. Epub 2017 Oct 3.
8
Atrial fibrillation, progression of coronary atherosclerosis and myocardial infarction.
Eur J Prev Cardiol. 2017 Mar;24(4):373-381. doi: 10.1177/2047487316679265. Epub 2016 Nov 12.
9
Non-antiarrhythmic agents for prevention of postoperative atrial fibrillation: role of statins.
Curr Opin Anaesthesiol. 2007 Feb;20(1):53-6. doi: 10.1097/ACO.0b013e328013d9fd.
10
Applying antithrombotic therapies to improve outcomes in patients with atrial fibrillation.
Am J Cardiol. 2013 Aug 15;112(4):S3. doi: 10.1016/j.amjcard.2013.06.003.
本文引用的文献
1
Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses.
J Am Coll Cardiol. 2011 Nov 1;58(19):1975-85. doi: 10.1016/j.jacc.2011.07.036.
2
Progression of new onset to established persistent atrial fibrillation: an implantable device-based analysis with implications for clinical classification of persistent atrial fibrillation.
J Interv Card Electrophysiol. 2011 Oct;32(1):7-15. doi: 10.1007/s10840-011-9601-1. Epub 2011 Jul 16.
3
A 12-year follow-up study of patients with newly diagnosed lone atrial fibrillation: implications of arrhythmia progression on prognosis: the Belgrade Atrial Fibrillation study.
Chest. 2012 Feb;141(2):339-347. doi: 10.1378/chest.11-0340. Epub 2011 May 26.
4
An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality.
Europace. 2010 May;12(5):626-33. doi: 10.1093/europace/euq109.
5
Racial disparities in awareness and treatment of atrial fibrillation: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.
Stroke. 2010 Apr;41(4):581-7. doi: 10.1161/STROKEAHA.109.573907. Epub 2010 Feb 26.
6
Atrial fibrillation in mainland China: epidemiology and current management.
Heart. 2009 Jul;95(13):1052-5. doi: 10.1136/hrt.2008.146589. Epub 2009 Mar 23.
7
Cardiology patient pages. A patient's guide to living with atrial fibrillation.
Circulation. 2008 May 20;117(20):e340-3. doi: 10.1161/CIRCULATIONAHA.108.780577.
8
Progression of paroxysmal atrial fibrillation to persistent atrial fibrillation in patients with bradyarrhythmias.
Am Heart J. 2007 Nov;154(5):884-92. doi: 10.1016/j.ahj.2007.06.045. Epub 2007 Sep 14.
9
Impact of "hybrid therapy" on long-term rhythm control and arrhythmia related hospitalizations in patients with drug-refractory persistent and permanent atrial fibrillation.
J Interv Card Electrophysiol. 2007 Mar;18(2):127-36. doi: 10.1007/s10840-007-9091-3. Epub 2007 Mar 20.
10
Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study.
Eur Heart J. 2006 Apr;27(8):949-53. doi: 10.1093/eurheartj/ehi825. Epub 2006 Mar 9.
Zotero 插件